MAPT and Alzheimer disease: Given the central role of glycosylation in modulating protein structure, signaling and immune recognition, alterations in glycosylation patterns have been increasingly linked to the pathogenesis of AD, particularly through their impact on amyloid precursor protein processing and tau protein stability.